Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib pharmacokinetic interaction study with sildenafil and bosentan in pulmonary arterial hypertension
2010-021344-17Phase 3Completed
- Sponsor
- Novartis
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of imatinib in pulmonary arterial hypertension (PAH), sponsored by Novartis. Primary endpoint: Pharmacokinetics analysis. Started Feb 2011; status: completed.
02
Drugs
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2010-021344-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021344-17.